250 related articles for article (PubMed ID: 38720772)
1. The antitumor action of endocannabinoids in the tumor microenvironment of glioblastoma.
Tang Y; Wang M; Yu J; Lv G; Wang Y; Yu B
Front Pharmacol; 2024; 15():1395156. PubMed ID: 38720772
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids are potential inhibitors of glioblastoma multiforme proliferation.
Duzan A; Reinken D; McGomery TL; Ferencz NM; Plummer JM; Basti MM
J Integr Med; 2023 Mar; 21(2):120-129. PubMed ID: 36805391
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids in the treatment of glioblastoma.
Buchalska B; Kamińska K; Owe-Larsson M; Cudnoch-Jędrzejewska A
Pharmacol Rep; 2024 Apr; 76(2):223-234. PubMed ID: 38457018
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy.
Dasram MH; Naidoo P; Walker RB; Khamanga SM
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338649
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid signaling in glioma.
Costas-Insua C; Guzmán M
Glia; 2023 Jan; 71(1):127-138. PubMed ID: 35322459
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
7. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy: a promising approach for glioma treatment.
Yasinjan F; Xing Y; Geng H; Guo R; Yang L; Liu Z; Wang H
Front Immunol; 2023; 14():1255611. PubMed ID: 37744349
[TBL] [Abstract][Full Text] [Related]
9. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
10. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme.
Raizer JJ
J Neurooncol; 2005 Aug; 74(1):77-86. PubMed ID: 16078112
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas.
Han M; Sun Y; Zhao W; Xiang G; Wang X; Jiang Z; Xue Z; Zhou W
Front Immunol; 2022; 13():1025286. PubMed ID: 36341396
[TBL] [Abstract][Full Text] [Related]
12. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
[TBL] [Abstract][Full Text] [Related]
13. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
Verdugo E; Puerto I; Medina MÁ
Cancer Commun (Lond); 2022 Nov; 42(11):1083-1111. PubMed ID: 36129048
[TBL] [Abstract][Full Text] [Related]
14. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
Pachocki CJ; Hol EM
J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
[TBL] [Abstract][Full Text] [Related]
15. Emerging Recombinant Oncolytic Poliovirus Therapies Against Malignant Glioma: A Review.
Dighe OR; Korde P; Bisen YT; Iratwar S; Kesharwani A; Vardhan S; Singh A
Cureus; 2023 Jan; 15(1):e34028. PubMed ID: 36814733
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine associated with photodynamic therapy for glioblastoma treatment.
de Paula LB; Primo FL; Tedesco AC
Biophys Rev; 2017 Oct; 9(5):761-773. PubMed ID: 28823025
[TBL] [Abstract][Full Text] [Related]
17. Tumor Vaccines for Malignant Gliomas.
Srinivasan VM; Ferguson SD; Lee S; Weathers SP; Kerrigan BCP; Heimberger AB
Neurotherapeutics; 2017 Apr; 14(2):345-357. PubMed ID: 28389997
[TBL] [Abstract][Full Text] [Related]
18. Cannabis Biomolecule Effects on Cancer Cells and Cancer Stem Cells: Cytotoxic, Anti-Proliferative, and Anti-Migratory Activities.
Peeri H; Koltai H
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454080
[TBL] [Abstract][Full Text] [Related]
19. γδ T cells as a potential therapeutic agent for glioblastoma.
Kang I; Kim Y; Lee HK
Front Immunol; 2023; 14():1273986. PubMed ID: 37928546
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell vaccine of gliomas: challenges from bench to bed.
Zheng Y; Ma X; Feng S; Zhu H; Chen X; Yu X; Shu K; Zhang S
Front Immunol; 2023; 14():1259562. PubMed ID: 37781367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]